Medtronic Equity 2024

Medtronic Aktienanalyse

What does Medtronic do?

Medtronic PLC is a globally leading medical technology company headquartered in Dublin, Ireland. The company was founded in 1949 by Earl Bakken and Palmer Hermundslie and has since developed a comprehensive portfolio of products in the field of medical devices and equipment. Medtronic's business model is focused on meeting the demand for innovative medical technology to improve the quality of life for patients and treat or alleviate diseases and disorders. The company strives to constantly invest in research and development to bring new and improved products to the market. Medtronic offers an extensive range of products that can be used in the fields of cardiology, neuromodulation, spinal surgery, diabetes, hearing aids, surgery, ophthalmology, infection prevention, percutaneous intervention procedures, and more. One of the most well-known product series is the pacemaker, which has been manufactured by Medtronic in a variety of models since 1957. In the field of neuromodulation, Medtronic is a leader in the development of implants that can treat various disorders of the nervous system. This includes deep brain stimulation (DBS) for Parkinson's disease, as well as spinal cord stimulation procedures for chronic pain and neurostimulation procedures for bladder, bowel, and gastrointestinal disorders.. In the field of spinal medicine, Medtronic offers a variety of devices that contribute to the stabilization of the spine and can be implemented through minimally invasive procedures. These include products such as plate systems, cages, spinal stabilizations, chamber drains, medication pumps, and more. In the field of diabetes, Medtronic focuses on the development of insulin pump systems that allow for more precise administration of insulin. The system also includes a sensor that continuously monitors blood sugar levels and can trigger insulin delivery as needed. Medtronic is also known for its efforts in infection prevention, offering products such as antimicrobial catheters, wound care, and hospital hygiene solutions. In addition to its products, the company is also involved in medical education and consulting. As part of these efforts, Medtronic develops training and education programs for physicians and healthcare personnel to enhance techniques and the use of devices and systems. Over the years, Medtronic has expanded its product offering through mergers and acquisitions. Currently, the company employs over 86,000 people in locations across more than 160 countries worldwide. Overall, Medtronic aims to drive innovation in medical technology and enable better healthcare for patients worldwide through its products and services. Medtronic ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Medtronic's Equity

Medtronic's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Medtronic's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Medtronic's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Medtronic's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Medtronic’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Medtronic stock

What is the equity of Medtronic this year?

Medtronic has equity of 50.21 B USD this year.

What was the equity of Medtronic compared to the previous year?

The equity of Medtronic has increased/decreased by -4.45% decreased compared to the previous year.

What impact does a high equity have on investors of Medtronic?

A high equity is advantageous for investors of Medtronic as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Medtronic?

A low equity can be a risk for investors of Medtronic, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Medtronic affect the company?

An increase in equity of Medtronic can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Medtronic affect the company?

A reduction in equity of Medtronic can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Medtronic?

Some factors that can affect the equity of Medtronic include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Medtronic so important for investors?

The equity of Medtronic is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Medtronic take to change the equity?

To change equity, Medtronic can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Medtronic pay?

Over the past 12 months, Medtronic paid a dividend of 2.09 USD . This corresponds to a dividend yield of about 2.42 %. For the coming 12 months, Medtronic is expected to pay a dividend of 2.14 USD.

What is the dividend yield of Medtronic?

The current dividend yield of Medtronic is 2.42 %.

When does Medtronic pay dividends?

Medtronic pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of Medtronic?

Medtronic paid dividends every year for the past 48 years.

What is the dividend of Medtronic?

For the upcoming 12 months, dividends amounting to 2.14 USD are expected. This corresponds to a dividend yield of 2.48 %.

In which sector is Medtronic located?

Medtronic is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medtronic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medtronic from 10/11/2024 amounting to 0.7 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Medtronic pay the last dividend?

The last dividend was paid out on 10/11/2024.

What was the dividend of Medtronic in the year 2023?

In the year 2023, Medtronic distributed 2.75 USD as dividends.

In which currency does Medtronic pay out the dividend?

The dividends of Medtronic are distributed in USD.